Pacific Biosciences of California, Inc. is a company in the U.S. stock market and it is a holding in 67 U.S.-traded ETFs. PACB has around 39.0M shares in the U.S. ETF market. The largest ETF holder of PACB is the ARK Genomic Revolution ETF (ARKG), with approximately 14.44M shares. Investors may also find of interest that the ETF with the largest allocation to PACB stock is ARK Genomic Revolution ETF (ARKG), with a portfolio weight of 5.37%. On average, U.S. ETFs allocate 0.41% of PACB to their portfolios.
Additionally, PACB is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with PACB as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%.